Tacrine‐induced increase in the release of spontaneous high quantal content events in Torpedo electric organ
Open Access
- 1 May 1994
- journal article
- Published by Wiley in British Journal of Pharmacology
- Vol. 112 (1) , 19-22
- https://doi.org/10.1111/j.1476-5381.1994.tb13022.x
Abstract
1 The anticholinesterases, tacrine (100 μm) and physostigmine (60 μm) had different effects on the amplitude distribution and kinetics of miniature endplate currents (m.e.p.cs) recorded extracellularly from the electric organ of Torpedo marmorata. 2 Tacrine increased the ratio of giant miniatures (larger than 4 mV of amplitude) to more than 20% of recorded spontaneous events. In the presence of physostigmine such events represented only 4%. 3 Both tacrine and physostigmine increased the rise time and the decay phase of normal-sized m.e.p.cs when compared to control conditions. Both effects were significantly greater for tacrine. 4 We have tested the specificity of the tacrine effect on ectoenzyme activities associated with plasma membranes of these pure cholinergic nerve endings. Tacrine does not act unspecifically on every ectoenzyme, because it is not able to block the ectoapyrase activity even at a concentration 100 fold greater than that required to inhibit 94% of AChE. 5 We conclude that the differential effects of tacrine and physostigmine can be explained in terms of undetermined presynaptic actions of tacrine, while comparable effects of the two compounds can be explained through a shared anticholinesterase activity.Keywords
This publication has 27 references indexed in Scilit:
- Quantal release of neurotransmitter and long-term potentiationCell, 1993
- The regulation of quantal sizeProgress in Neurobiology, 1991
- Tacrine: A pharmacological reviewProgress in Neurobiology, 1991
- Characterization of a synaptosomal ATP diphosphohydrolase from the electric organ of Torpedo marmorataBrain Research Bulletin, 1991
- 9-Amino-1,2,3,4-tetrahydroacridin-1-ols. Synthesis and evaluation as potential Alzheimer's disease therapeuticsJournal of Medicinal Chemistry, 1989
- 9-Amino-1,2,3,4-tetrahydroacridine (THA), an alleged drug for the treatment of Alzheimer's disease, inhibits acetylcholinesterase activity and slow outward K+ currentEuropean Journal of Pharmacology, 1987
- Kinetics of 9-aminoacridine block of single Na channels.The Journal of general physiology, 1984
- 4-Aminoquinoline-induced ‘giant’ miniature endplate potentials at mammalian neuromuscular junctionsProceedings of the Royal Society of London. B. Biological Sciences, 1982
- Isolation of pure cholinergic nerve endings from Torpedo electric organ. Evaluation of their metabolic properties.The Journal of cell biology, 1977
- A new and rapid colorimetric determination of acetylcholinesterase activityBiochemical Pharmacology, 1961